Clinical Trials · NCT01436201
A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Participants
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 24
- Start date
- Sep 2011
- Locations
- 1 site, United States
- Primary endpoint
- Pharmacokinetics: Area Under the Concentration Versus Time Curve (AUC) of Digoxin